Safety and Efficacy of Tocilizumab Versus Azathioprine in Neuromyelitis Optica Spectrum Disorders: a Randomized, Controlled, Open-label, Phase 2 Trial
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 23 Aug 2018
At a glance
- Drugs Tocilizumab (Primary) ; Azathioprine
- Indications Neuromyelitis optica
- Focus Therapeutic Use
- Acronyms TANGO
- 23 Aug 2018 Last checked against ClinicalTrials.gov record.
- 13 Aug 2018 Status changed from recruiting to active, no longer recruiting.
- 24 Nov 2017 New trial record